| Stage | FWONA | % of rev | FOXA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $4.6B | 100.00% | FOXA ×3.73 |
| Gross profit | $494M | 40.29% | $4.6B | 100.00% | FOXA +59.7pp |
| Operating income | $237M | 19.33% | $1.5B | 32.95% | FOXA +13.6pp |
| Pre-tax income | $244M | 19.90% | $1.3B | 28.07% | FOXA +8.2pp |
| Net income | $162M | 13.21% | $957M | 20.94% | FOXA +7.7pp |
| Stage | FWONA | FOXA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $4.6B100.00% | FOXA ×3.73 |
| Gross profit | 40.29%$494M | 100.00%$4.6B | FOXA +59.7pp |
| Operating income | 19.33%$237M | 32.95%$1.5B | FOXA +13.6pp |
| Pre-tax income | 19.90%$244M | 28.07%$1.3B | FOXA +8.2pp |
| Net income |
| 13.21%$162M |
| 20.94%$957M |
| FOXA +7.7pp |
None
No disclosed counterparties: FWONA.